miRNAs play an important role in the regulation of the immune response and inflammation in IBD, affecting various IL-10/STAT3, NF-Κb signaling pathways, Th1/Th17 regulation, and modulation of the NLRP3 inflammasome. Here, STAT3 is linked to inflammatory bowel disease.